Gene · 1052
CEBPD: CCAAT enhancer binding protein delta
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CEBPD: CCAAT enhancer binding protein delta. Genes, record 1052. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1052
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P49716 | CCAAT/enhancer-binding protein delta | 269 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents32
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026511162 A | 2026-04-10 | 19 | P49716 | Espacenet |
| EP 4687924 A2 | 2026-02-11 | 19 | P49716 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 40367 | P49716 | Espacenet |
| KR 1020250166262 A | 2025-11-27 | 19 | P49716 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 12002 | P49716 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 6090 | P49716 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 14826 | P49716 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 12002 | P49716 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 14826 | P49716 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 6090 | P49716 | Espacenet |
1 to 10 of 32
See all 32 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,506
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CEBPD papers | Newest fiscal year |
|---|---|---|---|
| ZIABC010307 | Molecular, Cellular and Systemic Mechanisms of Breast Cancer Metastasis | 19 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 17 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 8 | 2025 |
| R01GM085319 | Function of Sequence-specific RNA Binding Proteins | 7 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| P30CA013696 | Cancer Center Support Grant | 5 | 2025 |
| P30ES013508 | Center of Excellence in Environmental Toxicology | 5 | 2025 |
| P40OD010440 | Caenorhabditis Genetics Center | 5 | 2025 |
| R01NS098819 | Molecular effects of metformin, PKR and TBI on C9orf72 ALS/FTD | 5 | 2025 |
| P30CA060553 | The Robert H. Lurie Comprehensive Cancer Center | 4 | 2025 |
1 to 10 of 2,506Source NIH's project files
See all 2,506 nih grantsPapers3,093
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NRF2-CDH6-CEBPD axis suppresses ferroptosis and drives cisplatin resistance in non-small cell lung cancer. | J Cell Commun Signal | 2026 | 42787592 | PubTator, text mining | PubMed |
| Transcriptomic associations and biomarkers in ANCA‑associated Glomerulonephritis and IgG4‑related Disease: A bioinformatics and machine learning study. | PLoS One | 2026 | 42784621 | PubTator, text mining | PubMed |
| Toward a more precise immunophenotypic and molecular definition of human cMoPs. | Cell Rep | 2026 | 42747963 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis identifies decreased CEBPB and PAX8 expression associated with immune landscape differences between medullary and papillary thyroid carcinoma. | Transl Cancer Res | 2026 | 42724389 | PubTator, text mining | PubMed |
| C/EBPδ regulates SPHK1-dependent excessive autophagy in decidualization defects of chronic endometritis. | Reproduction | 2026 | 42704675 | PubTator, text mining | PubMed |
| Single-cell analysis identifies a VIM+ glioma stem-like vascular-immune state linked to myeloid OSM signaling and CEBPD activity. | Front Immunol | 2026 | 42643588 | PubTator, text mining | PubMed |
| THSD7A Exacerbates Atherosclerosis via Activation of Signaling Axis αvβ3/CEBPD/IL1A. | Adv Sci (Weinh) | 2026 | 42635977 | PubTator, text mining | PubMed |
| Tryptophan Metabolism-Related Biomarkers in Acute Myocardial Infarction Identified by Machine Learning. | J Vis Exp | 2026 | 42611744 | PubTator, text mining | PubMed |
| Hepatic responses as potential biomarkers of idiosyncratic drug reaction risk. | Toxicol Sci | 2026 | 42523165 | PubTator, text mining | PubMed |
| Upregulated CD177 on neutrophils is implicated in sepsis pathogenesis and necroptosis-driven inflammation. | Front Immunol | 2026 | 42490847 | PubTator, text mining | PubMed |
1 to 10 of 3,093
See all 3,093 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/1052
GET https://conductscience.org/api/genes/v1/1052/patents?page=2